57 results
DEFA14A
VERV
Verve Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
7:56am
. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained … number located in the box above available when you access the website and follow the instructions. Copyright © 2024 BetaNXT, Inc. or its affiliates
8-K
VERV
Verve Therapeutics Inc
2 Apr 24
Other Events
7:13am
tolerated in these trials. Second, the incorporation of GalNAc allows the LNP in VERVE-102 to access liver cells using either the asialoglycoprotein
8-K
EX-99.1
ssp0ruxapr cc
27 Feb 24
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
EX-1.1
dqdxx 9ezra
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
npusp8ia439nkh9t
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
ytl r2sw3
28 Nov 23
Prospectus supplement for primary offering
4:25pm
DEFA14A
t03s9cahpc3j0jb6rk
28 Apr 23
Additional proxy soliciting materials
7:49am
S-3ASR
gpdb7klq2j
23 Sep 22
Automatic shelf registration
4:08pm